3-[4-(6-fluoro-1H-indol-3-yl)piperidin-1-yl]-5-methyl-1,2,4-oxadiazole;5-[4-(6-fluoro-1H-indol-3-yl)piperidin-1-yl]-3-methyl-1,2,4-oxadiazole;3-(3-methyl-4-methylsulfonylpiperazin-1-yl)-1H-indole;5-methyl-3-(1-methylsulfonylpiperidin-4-yl)-1,3-dihydroindol-2-one

C61H73F2N13O7S2 — CID 159931103

IUPAC3-[4-(6-fluoro-1H-indol-3-yl)piperidin-1-yl]-5-methyl-1,2,4-oxadiazole;5-[4-(6-fluoro-1H-indol-3-yl)piperidin-1-yl]-3-methyl-1,2,4-oxadiazole;3-(3-methyl-4-methylsulfonylpiperazin-1-yl)-1H-indole;5-methyl-3-(1-methylsulfonylpiperidin-4-yl)-1,3-dihydroindol-2-one
SMILESCC1CN(c2c[nH]c3ccccc23)CCN1S(C)(=O)=O.Cc1ccc2c(c1)C(C1CCN(S(C)(=O)=O)CC1)C(=O)N2.Cc1nc(N2CCC(c3c[nH]c4cc(F)ccc34)CC2)no1.Cc1noc(N2CCC(c3c[nH]c4cc(F)ccc34)CC2)n1
InChIInChI=1S/2C16H17FN4O.C15H20N2O3S.C14H19N3O2S/c1-10-19-16(20-22-10)21-6-4-11(5-7-21)14-9-18-15-8-12(17)2-3-13(14)15;1-10-19-16(22-20-10)21-6-4-11(5-7-21)14-9-18-15-8-12(17)2-3-13(14)15;1-10-3-4-13-12(9-10)14(15(18)16-13)11-5-7-17(8-6-11)21(2,19)20;1-11-10-16(7-8-17(11)20(2,18)19)14-9-15-13-6-4-3-5-12(13)14/h2*2-3,8-9,11,18H,4-7H2,1H3;3-4,9,11,14H,5-8H2,1-2H3,(H,16,18);3-6,9,11,15H,7-8,10H2,1-2H3
InChIKeyNZQMEIAFWDXXTO-UHFFFAOYSA-N
MW1202.47 g/mol
LogP10.11
Rot. Bonds8

About 3-[4-(6-fluoro-1H-indol-3-yl)piperidin-1-yl]-5-methyl-1,2,4-oxadiazole;5-[4-(6-fluoro-1H-indol-3-yl)piperidin-1-yl]-3-methyl-1,2,4-oxadiazole;3-(3-methyl-4-methylsulfonylpiperazin-1-yl)-1H-indole;5-methyl-3-(1-methylsulfonylpiperidin-4-yl)-1,3-dihydroindol-2-one

3-[4-(6-fluoro-1H-indol-3-yl)piperidin-1-yl]-5-methyl-1,2,4-oxadiazole;5-[4-(6-fluoro-1H-indol-3-yl)piperidin-1-yl]-3-methyl-1,2,4-oxadiazole;3-(3-methyl-4-methylsulfonylpiperazin-1-yl)-1H-indole;5-methyl-3-(1-methylsulfonylpiperidin-4-yl)-1,3-dihydroindol-2-one (PubChem CID 159931103) has the molecular formula C61H73F2N13O7S2 and a molecular weight of 1202.47 g/mol. Its IUPAC name is 3-[4-(6-fluoro-1H-indol-3-yl)piperidin-1-yl]-5-methyl-1,2,4-oxadiazole;5-[4-(6-fluoro-1H-indol-3-yl)piperidin-1-yl]-3-methyl-1,2,4-oxadiazole;3-(3-methyl-4-methylsulfonylpiperazin-1-yl)-1H-indole;5-methyl-3-(1-methylsulfonylpiperidin-4-yl)-1,3-dihydroindol-2-one.

Molecular Properties

Compound Name3-[4-(6-fluoro-1H-indol-3-yl)piperidin-1-yl]-5-methyl-1,2,4-oxadiazole;5-[4-(6-fluoro-1H-indol-3-yl)piperidin-1-yl]-3-methyl-1,2,4-oxadiazole;3-(3-methyl-4-methylsulfonylpiperazin-1-yl)-1H-indole;5-methyl-3-(1-methylsulfonylpiperidin-4-yl)-1,3-dihydroindol-2-one
PubChem CID159931103
Molecular FormulaC61H73F2N13O7S2
Molecular Weight1202.47 g/mol
Exact Mass1201.52
IUPAC Name3-[4-(6-fluoro-1H-indol-3-yl)piperidin-1-yl]-5-methyl-1,2,4-oxadiazole;5-[4-(6-fluoro-1H-indol-3-yl)piperidin-1-yl]-3-methyl-1,2,4-oxadiazole;3-(3-methyl-4-methylsulfonylpiperazin-1-yl)-1H-indole;5-methyl-3-(1-methylsulfonylpiperidin-4-yl)-1,3-dihydroindol-2-one
SMILESCC1CN(c2c[nH]c3ccccc23)CCN1S(C)(=O)=O.Cc1ccc2c(c1)C(C1CCN(S(C)(=O)=O)CC1)C(=O)N2.Cc1nc(N2CCC(c3c[nH]c4cc(F)ccc34)CC2)no1.Cc1noc(N2CCC(c3c[nH]c4cc(F)ccc34)CC2)n1
InChIInChI=1S/2C16H17FN4O.C15H20N2O3S.C14H19N3O2S/c1-10-19-16(20-22-10)21-6-4-11(5-7-21)14-9-18-15-8-12(17)2-3-13(14)15;1-10-19-16(22-20-10)21-6-4-11(5-7-21)14-9-18-15-8-12(17)2-3-13(14)15;1-10-3-4-13-12(9-10)14(15(18)16-13)11-5-7-17(8-6-11)21(2,19)20;1-11-10-16(7-8-17(11)20(2,18)19)14-9-15-13-6-4-3-5-12(13)14/h2*2-3,8-9,11,18H,4-7H2,1H3;3-4,9,11,14H,5-8H2,1-2H3,(H,16,18);3-6,9,11,15H,7-8,10H2,1-2H3
InChIKeyNZQMEIAFWDXXTO-UHFFFAOYSA-N
XLogP10.11
TPSA238.79 Ų
H-Bond Donors4
H-Bond Acceptors14
Rotatable Bonds8
Heavy Atoms85
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001202.47
LogP ≤ 510.11
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1014

Analyze 3-[4-(6-fluoro-1H-indol-3-yl)piperidin-1-yl]-5-methyl-1,2,4-oxadiazole;5-[4-(6-fluoro-1H-indol-3-yl)piperidin-1-yl]-3-methyl-1,2,4-oxadiazole;3-(3-methyl-4-methylsulfonylpiperazin-1-yl)-1H-indole;5-methyl-3-(1-methylsulfonylpiperidin-4-yl)-1,3-dihydroindol-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[4-(6-fluoro-1H-indol-3-yl)piperidin-1-yl]-5-methyl-1,2,4-oxadiazole;5-[4-(6-fluoro-1H-indol-3-yl)piperidin-1-yl]-3-methyl-1,2,4-oxadiazole;3-(3-methyl-4-methylsulfonylpiperazin-1-yl)-1H-indole;5-methyl-3-(1-methylsulfonylpiperidin-4-yl)-1,3-dihydroindol-2-one?
The IUPAC name of 3-[4-(6-fluoro-1H-indol-3-yl)piperidin-1-yl]-5-methyl-1,2,4-oxadiazole;5-[4-(6-fluoro-1H-indol-3-yl)piperidin-1-yl]-3-methyl-1,2,4-oxadiazole;3-(3-methyl-4-methylsulfonylpiperazin-1-yl)-1H-indole;5-methyl-3-(1-methylsulfonylpiperidin-4-yl)-1,3-dihydroindol-2-one (CID 159931103) is 3-[4-(6-fluoro-1H-indol-3-yl)piperidin-1-yl]-5-methyl-1,2,4-oxadiazole;5-[4-(6-fluoro-1H-indol-3-yl)piperidin-1-yl]-3-methyl-1,2,4-oxadiazole;3-(3-methyl-4-methylsulfonylpiperazin-1-yl)-1H-indole;5-methyl-3-(1-methylsulfonylpiperidin-4-yl)-1,3-dihydroindol-2-one.
What is the SMILES notation for 3-[4-(6-fluoro-1H-indol-3-yl)piperidin-1-yl]-5-methyl-1,2,4-oxadiazole;5-[4-(6-fluoro-1H-indol-3-yl)piperidin-1-yl]-3-methyl-1,2,4-oxadiazole;3-(3-methyl-4-methylsulfonylpiperazin-1-yl)-1H-indole;5-methyl-3-(1-methylsulfonylpiperidin-4-yl)-1,3-dihydroindol-2-one?
The canonical SMILES for 3-[4-(6-fluoro-1H-indol-3-yl)piperidin-1-yl]-5-methyl-1,2,4-oxadiazole;5-[4-(6-fluoro-1H-indol-3-yl)piperidin-1-yl]-3-methyl-1,2,4-oxadiazole;3-(3-methyl-4-methylsulfonylpiperazin-1-yl)-1H-indole;5-methyl-3-(1-methylsulfonylpiperidin-4-yl)-1,3-dihydroindol-2-one is CC1CN(c2c[nH]c3ccccc23)CCN1S(C)(=O)=O.Cc1ccc2c(c1)C(C1CCN(S(C)(=O)=O)CC1)C(=O)N2.Cc1nc(N2CCC(c3c[nH]c4cc(F)ccc34)CC2)no1.Cc1noc(N2CCC(c3c[nH]c4cc(F)ccc34)CC2)n1.
What is the InChIKey of 3-[4-(6-fluoro-1H-indol-3-yl)piperidin-1-yl]-5-methyl-1,2,4-oxadiazole;5-[4-(6-fluoro-1H-indol-3-yl)piperidin-1-yl]-3-methyl-1,2,4-oxadiazole;3-(3-methyl-4-methylsulfonylpiperazin-1-yl)-1H-indole;5-methyl-3-(1-methylsulfonylpiperidin-4-yl)-1,3-dihydroindol-2-one?
The InChIKey is NZQMEIAFWDXXTO-UHFFFAOYSA-N. The full InChI is InChI=1S/2C16H17FN4O.C15H20N2O3S.C14H19N3O2S/c1-10-19-16(20-22-10)21-6-4-11(5-7-21)14-9-18-15-8-12(17)2-3-13(14)15;1-10-19-16(22-20-10)21-6-4-11(5-7-21)14-9-18-15-8-12(17)2-3-13(14)15;1-10-3-4-13-12(9-10)14(15(18)16-13)11-5-7-17(8-6-11)21(2,19)20;1-11-10-16(7-8-17(11)20(2,18)19)14-9-15-13-6-4-3-5-12(13)14/h2*2-3,8-9,11,18H,4-7H2,1H3;3-4,9,11,14H,5-8H2,1-2H3,(H,16,18);3-6,9,11,15H,7-8,10H2,1-2H3.
What are the key properties of 3-[4-(6-fluoro-1H-indol-3-yl)piperidin-1-yl]-5-methyl-1,2,4-oxadiazole;5-[4-(6-fluoro-1H-indol-3-yl)piperidin-1-yl]-3-methyl-1,2,4-oxadiazole;3-(3-methyl-4-methylsulfonylpiperazin-1-yl)-1H-indole;5-methyl-3-(1-methylsulfonylpiperidin-4-yl)-1,3-dihydroindol-2-one?
3-[4-(6-fluoro-1H-indol-3-yl)piperidin-1-yl]-5-methyl-1,2,4-oxadiazole;5-[4-(6-fluoro-1H-indol-3-yl)piperidin-1-yl]-3-methyl-1,2,4-oxadiazole;3-(3-methyl-4-methylsulfonylpiperazin-1-yl)-1H-indole;5-methyl-3-(1-methylsulfonylpiperidin-4-yl)-1,3-dihydroindol-2-one has a molecular weight of 1202.47 g/mol, XLogP of 10.11, 8 rotatable bonds, 4 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[4-(6-fluoro-1H-indol-3-yl)piperidin-1-yl]-5-methyl-1,2,4-oxadiazole;5-[4-(6-fluoro-1H-indol-3-yl)piperidin-1-yl]-3-methyl-1,2,4-oxadiazole;3-(3-methyl-4-methylsulfonylpiperazin-1-yl)-1H-indole;5-methyl-3-(1-methylsulfonylpiperidin-4-yl)-1,3-dihydroindol-2-one is sourced from PubChem (CID 159931103), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).